35 data-science-phd Fellowship positions at Center for Drug Evaluation and Research (CDER)

FDA Postdoctoral Glyco-technology Lab Fellowship

for information about the valid immigration statuses that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge

FDA Pharmacovigilance Fellowship: Data Retrieval and Analysis Strategies

) of the different search terms/strategies using a retrospective data set from prior DPV reviews of anaphylaxis and using a new prospective data set reviewed by an allergist, 2) compare and contrast the performance

FDA Fellowship for Clinical Pharmacology Innovative Data Analytics Faculty Program

*Applications will be reviewed on a rolling-basis. A research opportunity is available in the Office of Translational Sciences (OTS), Office of Clinical Pharmacology (OCP) at the Center for Drug

FDA Bioinformatics Fellowship

software solutions to facilitate the review of toxicology study data by FDA CDER pharmacology/toxicology reviewers. The methods developed may potentially be incorporated into existing software tools or a new

FDA Fellowship in Comparative Gaps Analysis in Sickle Cell Disease

variable manifestations from one patient to the next. There is also a lack of consistent scientific data to facilitate informed regulatory decision-making that may lead to significant health improvements in

FDA Near Real Time Surveillance of the Overdose Crisis Fellowship

Research (CDER), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), located at Silver Spring, Maryland. The Center for Drug Evaluation and Research (CDER) performs an essential

CDER Fellowship in Natural History for Rare Pediatric Viral Disease

diseases caused by viral infections. In the first study, the participant would join the FDA study team to analyze data collected from retrospective chart reviews at 10 large pediatric transplant centers in

FDA Development of Cell-based Bioassays Postdoctoral Fellowship

mouse models. Learning Objectives: The participant will be trained in classical molecular biology, cell biology and immunology by developing cell-based bioassays. Under the guidance of the mentor

FDA Fellowship in Optimizing Drug Dosing in Geriatric Populations

on high quality evidence. Evaluating methods that are viable alternatives to clinical PK/PD studies in providing reliable information for appropriate dosing in geriatric populations is vital for ensuring

FDA Fellowship in Risk-Based Assessment & Inspections

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Office of Strategic Programs/Office of Business Informatics, Center for Drug